Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study

AIM: To evaluate the safety and efficacy of sorafenib plus transarterial chemoembolization (TACE) treatment for intermediate hepatocellular carcinoma (HCC). METHODS: Sixty-seven patients with intermediate-stage [Barcelona Clinic liver cancer stage B (BCLC-B)] HCC who were treated with sorafenib plus...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Xue-Fen, Ke, Yang, Bao, Tian-Hao, Tang, Hao-Ran, Wu, Xue-Song, Shi, Zhi-Tian, Lin, Jie, Zhang, Zhi-Xian, Gu, Hou, Wang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955731/
https://www.ncbi.nlm.nih.gov/pubmed/29774219
http://dx.doi.org/10.12998/wjcc.v6.i5.74

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955731/
https://www.ncbi.nlm.nih.gov/pubmed/29774219
http://dx.doi.org/10.12998/wjcc.v6.i5.74

Ejemplares similares